Process for the preparation of 2-imino-thiazolidin-4-one derivatives
AssigneeActelion Pharmaceuticals Ltd.
InventorsStefan Abele, Martin Bolli, Gunther Schmidt
Life of this patent
Estimating the term…
Abstract
The present invention relates to a new process for the preparation of 2-imino-thiazolidin-4-one compounds of the Formula (I) and (II) and to compounds of Formula (II) as such. The present compounds of Formula (II) can be used as intermediates in the preparation of thiazolidin-4-one derivatives of the General Formula (II), said derivatives being described in WO 2005/054215. These compounds of General Formula (II) are described in WO 2005/054215 to act as immunosuppressive agents.
Claims19
A process for the preparation of a compound of the Formula (I):
- wherein
- R1 represents phenyl which is optionally mono-, di- or tri-substituted wherein the substituents are independently selected from C1-7-alkyl and halogen;
- and
- R2 represents C1-7-alkyl;
- which process comprises reacting a compound of the formula R1—N═C═S, wherein R1 is as defined for Formula (I), with a compound of the formula R2—NH2, wherein R2 is as defined for Formula (I), followed by reaction with bromo-acetyl bromide and a pyridine base in the presence of the solvent dichloromethane.
A process for the preparation of a compound of the Formula (III):
- wherein
- R14 represents phenyl which is optionally mono-, di- or tri-substituted wherein the substituents are independently selected from C1-7-alkyl and halogen;
- R15 represents C1-7-alkyl;
- R16 represents hydrogen, hydroxy, C1-7-alkoxy, or halogen;
- R17 represents hydrogen, lower alkyl, or hydroxymethyl;
- R18, R19, R21 and R22 each represents independently hydrogen or methyl;
- R20 represents hydrogen or lower alkyl, and in case m represents the integer 1, R20 in addition represents lower alkoxy, hydroxy, —NH2, —NHR5 or —NR5R6, wherein R5 and R6 each represents independently lower alkyl;
- R23 represents hydrogen, lower alkyl, hydroxycarbonyl-lower alkyl, 1-glyceryl, or 2-glyceryl;
- and
- m represents the integer 0 or 1;
- or a pharmaceutically acceptable salt thereof;
- and wherein the terms “lower alkyl” and “lower alkoxy” have the following meanings:
- “lower alkyl”, alone or in combination with other groups, means saturated, straight or branched chain groups with one to seven carbon atoms;
- and
- “lower alkoxy” means an R—O group, wherein R is a lower alkyl;
- which process comprises reacting a compound of the formula R14—N═C═S, wherein R14 is as defined for Formula (III), with a compound of the formula R15—NH2, wherein R15 is as defined for Formula (III), followed by reaction with bromo-acetyl bromide and a pyridine base in the presence of the solvent dichloromethane.
Dependencies are inferred from the claim text.